Viread (300 mg Tenofovir disoproxil fumarate) once daily

TERMINATED · PHASE4 · HIV Infections

terminated

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.